Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful eradication of residual bcr-abl-positive clones by donor leukocyte transfusion in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia after peripheral blood stem cell transplantation.

× No keyword cloud information.

12 in total

1. Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes.

Authors: F Keil; P Kalhs; O A Haas; G Fritsch; E Reiter; C Mannhalter; K Lechner; G Leitner; H T Greinix
Journal: Br J Haematol Date: 1997-04 Impact factor: 6.998

2. Haematological remission induced by donor leukocytes infusion in a case of Philadelphia positive acute lymphoblastic leukaemia relapsing after allogeneic bone marrow transplantation.

Authors: M H Saw; A Teh; H C Wong; J Bosco
Journal: Int J Hematol Date: 1997-02 Impact factor: 2.490

3. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.

Authors: M Yazaki; M Andoh; T Ito; T Ohno; Y Wada
Journal: Bone Marrow Transplant Date: 1997-02 Impact factor: 5.483

4. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.

Authors: S Shiobara; S Nakao; M Ueda; H Yamazaki; S Takahashi; S Asano; H Yabe; S Kato; S Imoto; A Maruta; T Yoshida; H Gondo; Y Morishima; Y Kodera
Journal: Bone Marrow Transplant Date: 2000-10 Impact factor: 5.483

5. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.

Authors: K Inai; Y Wano; S Yamamoto; Y Ikebata; H Iwasaki; H Tsutani; H Naiki; T Ueda
Journal: Anticancer Res Date: 1999 Nov-Dec Impact factor: 2.480

6. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia.

Authors: F Dazzi; R M Szydlo; C Craddock; N C Cross; J Kaeda; A Chase; E Olavarria; F van Rhee; E Kanfer; J F Apperley; J M Goldman
Journal: Blood Date: 2000-01-01 Impact factor: 22.113

7. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.

Authors: J Radich; G Gehly; A Lee; R Avery; E Bryant; S Edmands; T Gooley; P Kessler; J Kirk; P Ladne; E D Thomas; F R Appelbaum
Journal: Blood Date: 1997-04-01 Impact factor: 22.113

8. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.

Authors: T Ueda; S Miyawaki; N Asou; Y Kuraishi; A Hiraoka; K Kuriyama; S Minami; T Ohshima; T Ino; J Tamura; A Kanamaru; K Nishikawa; M Tanimoto; H Oh; K Saito; K Nagata; T Naoe; O Yamada; Y Urasaki; T Sakura; R Ohno
Journal: Int J Hematol Date: 1998-10 Impact factor: 2.490

9. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Authors: H J Kolb; A Schattenberg; J M Goldman; B Hertenstein; N Jacobsen; W Arcese; P Ljungman; A Ferrant; L Verdonck; D Niederwieser; F van Rhee; J Mittermueller; T de Witte; E Holler; H Ansari
Journal: Blood Date: 1995-09-01 Impact factor: 22.113

10. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.

Authors: S Slavin; E Naparstek; A Nagler; A Ackerstein; S Samuel; J Kapelushnik; C Brautbar; R Or
Journal: Blood Date: 1996-03-15 Impact factor: 22.113